Sharon J. Sha

Neurology

213 Quarry Rd
Palo Alto, CA 94304

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.

EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.

Journal: Neurology

Published: August 26, 2026

Dissociable structural and molecular pathways of age-related change in sustained attention.

Dissociable structural and molecular pathways of age-related change in sustained attention.

Journal: bioRxiv : the preprint server for biology

Published: July 10, 2026

Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's disease.

Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's disease.

Journal: medRxiv : the preprint server for health sciences

Published: February 06, 2026

Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADS.

Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADS.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 27, 2026

Effects of α-synuclein pathology on synaptic dysfunction and clinical outcomes in normal aging.

Effects of α-synuclein pathology on synaptic dysfunction and clinical outcomes in normal aging.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 23, 2025

Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS.

Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: December 17, 2025

Plasma proteomic signatures of preclinical Alzheimer's disease biomarkers and memory in clinically unimpaired older adults.

Plasma proteomic signatures of preclinical Alzheimer's disease biomarkers and memory in clinically unimpaired older adults.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Relationship between age and severity of cognitive impairment at diagnosis for early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI.

Relationship between age and severity of cognitive impairment at diagnosis for early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: November 03, 2025

Plasma proteomic signatures of preclinical Alzheimer's disease in clinically unimpaired older adults.

Plasma proteomic signatures of preclinical Alzheimer's disease in clinically unimpaired older adults.

Journal: Molecular neurodegeneration

Published: October 20, 2025

Relationships of CSF biomarkers to cortical atrophy in early-onset Alzheimer's disease.

Relationships of CSF biomarkers to cortical atrophy in early-onset Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 18, 2025

Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease.

Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease.

Journal: Brain communications

Published: September 10, 2025

Alzheimer's disease polygenic risk in early- and late-onset Alzheimer's disease.

Alzheimer's disease polygenic risk in early- and late-onset Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: August 29, 2025

Showing 1-12 of 72

Last Updated: 09/26/2026